对帕金森病的iPS细胞衍生的多巴胺基细胞的I/II期试验
Nobukatsu Sawamoto1, Daisuke Doi2, Etsuro Nakanishi1
1Department of Neurology, Kyoto University Graduate School of Medicine, Kyoto, Japan.
Nature
|April 16, 2025
概括
诱导多能干细胞 (iPS) 治疗帕金森病显示出有前途的安全性和潜在益处. 在临床试验中,来自iPS细胞的多巴胺原体存活下来,产生多巴胺,并改善运动症状.
科学领域:
- 神经科学
- 复原医学
- 干细胞生物学
背景情况:
- 帕金森病是由多巴胺神经元的损失引起的,导致运动缺陷.
- 胎儿组织细胞治疗PD面临安全和道德挑战.
- 诱导多能干细胞 (iPS) 是一种潜在的 PD 治疗替代方案.
研究的目的:
- 评估在帕金森病患者中移植iPS细胞衍生的多巴胺原体的安全性和有效性.
- 评估移植后的运动功能,多巴胺产量和不良事件.
主要方法:
- 一个I/II期临床试验,涉及7名帕金森病患者 (年龄在50至69岁之间).
- 来自iPS细胞的双边多巴胺基原体移植.
- 在24个月内监测安全性,不良事件,运动分数 (MDS-UPDRS) 和多巴胺产量 (18F-DOPA PET).
主要成果:
- 没有报告严重的不良事件;发生了73起轻度至中度的不良事件.
- 六分之四的患者表现出运动改善 (MDS- UPDRS OFF和ON分数).
- 在骨中18F-DOPA吸收增加了44.7%,表明多巴胺的产生恢复了.
结论:
- 在帕金森病患者中,全基性iPS细胞衍生的多巴胺基基基因是安全的,并且可以存活.
- 治疗显示了潜在的临床益处,包括运动症状的改善.
- 这项研究支持基于iPS细胞的再生医学对帕金森病的治疗潜力.
更多相关视频
相关概念视频
EPS and iPS Cells in Disease Research
2.8K
Embryonic and induced pluripotent stem cells are excellent models for disease research because of their ability to self-renew and differentiate into most cell types. Somatic cells from a patient are isolated and reprogrammed into induced pluripotent stem cells or iPSCs. These iPSCs are later differentiated into the desired cell type, which mirrors the diseased cell of the patient. In this way, disease models have been created for investigating diseases such as Down syndrome, type I diabetes,...
2.8K
iPS Cell Differentiation
2.6K
The ability of induced pluripotent stem cells or iPSCs to differentiate into most body cell types has stimulated repair and regenerative medicine research over the past few decades. iPSC-derived blood cells, hepatocytes, beta islet cells, cardiomyocytes, neurons, and other cell types can repair injuries or regenerate damaged tissue in diseases such as diabetes and neurodegenerative disorders.
2.6K
Induced Pluripotent Stem Cells
21.7K
Stem cells are undifferentiated cells that divide and produce different types of cells. Ordinarily, cells that have differentiated into a specific cell type are post-mitotic—that is, they no longer divide. However, scientists have found a way to reprogram these mature cells so that they “de-differentiate” and return to an unspecialized, proliferative state. These cells are also pluripotent like embryonic stem cells—able to produce all cell types—and are therefore...
21.7K


